Grassley, Wyden Consider Reviving Trump’s Defunct Drug Rebate Plan

By Donna Haseley / July 25, 2019 at 1:25 PM
A measure to ban drug rebates that aren’t shared at the point of sale might be added to the Senate Finance Committee’s drug pricing bill before a floor vote, Senate Finance Chair Chuck Grassley (R-IA) and ranking Democrat Ron Wyden (OR) said Thursday (July 25) during the bill’s markup. HHS recently scrapped a rule that would have banned the rebates because the Congressional Budget Office said it would have increased rebates and government spending, and it isn’t clear how the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.